Alpha 1 Lung Disease Market
According to Intent Market Research, the Alpha 1 Lung Disease Market is expected to grow from USD 5.0 Billion in 2024-e at a CAGR of 21.5% to touch USD 16.2 Billion by 2030. The Alpha 1 Lung Disease Market is dominated by key players such as, Grifols S.A., CSL Behring, Shire (now part of Takeda Pharmaceutical Company), Vertex Pharmaceuticals, AstraZeneca, and Boehringer Ingelheim.